Disclosed is a novel class of substituted imidazole compounds, pharmaceutical
compositions containing them and uses of these compounds in the treatment and/or
prevention of diseases and disorders related to the histamine H3 receptor. More
particularly, these compounds are useful for the treatment and/or prevention of
diseases and disorders in which an interaction with the histamine H3 receptor is
beneficial. These imidazoles compounds have the formula I
##STR1##
wherein R1, R2, R3, R4, R5,
R6, A, X, Y and Z are as defined in the specification.